Clinical Trial Update: Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) [Phase 1]

View source ↗

Summary

This report notes the completion of a Phase 1 clinical trial evaluating azacitidine as maintenance therapy after allogeneic bone marrow transplantation in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Leukemia | Phase 1 | Status: COMPLETED